Synaptogenix Inc (SNPX)

[runncoach]

We are where we should have been a couple years ago. Memantine from that first trial screwed us out of a couple years and it seems developing the oral synthetic has taken longer than anticipated. It also sounds like they (with academic partners) do extensive preclinical before just starting trials based on hopes. I do hope to see them launch Fragile X and MS this spring but who knows. Also really keen on promoting PKCe as a biomarker. More than usual. Makes me wonder if the diagnostic tool may be about to gain FDA approval. Wish more people had tuned in today because it was a chance to get questions answered. I wish I had been better prepared myself but did get through.

Also will be interesting to see how many of those 1 year warrants get cashed in this year. Could be another 20 million in the coffers but could keep a lid on the share price.